Status:
RECRUITING
Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®
Lead Sponsor:
University Hospital, Limoges
Conditions:
Viral Hepatitis
Eligibility:
All Genders
18+ years
Brief Summary
The "Scanvir" concept aims to achieve barriers to HCV screening and treating of marginalized patients. The concept is applicable to other various populations and territories and should effectively imp...
Detailed Description
According to the French recommendations, eliminating hepatitis C virus by 2025 could be a realistic public health goal in this country. A total of 71,466 patients had treatment initiation between 2015...
Eligibility Criteria
Inclusion
- Adult 18 and over
- Patient frequenting an unconventional structure "outside the walls" or referred by a professional in the care sector
- Patient not opposed to research
Exclusion
- Age under 18
- Patient opposed to research
Key Trial Info
Start Date :
June 5 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 5 2035
Estimated Enrollment :
2300 Patients enrolled
Trial Details
Trial ID
NCT06904820
Start Date
June 5 2025
End Date
June 5 2035
Last Update
August 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Limoges University Hospital
Limoges, France, 87000